Aptus Pharma's board has approved a preferential issue of 16,02,870 equity shares at Rs 280 each, aiming to raise approximately Rs 44.88 crore. The company also scheduled its 16th Annual General Meeting for September 14, 2026.
Aptus Pharma Approves Rs 44.88 Crore Preferential Issue
16,02,870 Equity Shares to be issued at Rs 280 per share.
Reader Takeaway: Capital raise is formalized; AGM date set. Track allotment completion.
What just happened
Aptus Pharma Limited's board of directors met on August 17, 2026, and approved a preferential issue of 16,02,870 equity shares. The issue price is fixed at Rs 280 per share, with a face value of Rs 10. This move is expected to raise approximately Rs 44.88 crore. The board also finalized the terms of the issue based on a valuation report dated August 14, 2026, and identified 190 allottees.
Compliance certificates from the Practicing Company Secretary and the Statutory Auditor were taken on record, confirming adherence to SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013.
Why this matters
This approval marks a significant step for Aptus Pharma in its capital-raising efforts. The funds raised will likely bolster the company's financial resources for future growth initiatives or working capital needs. For investors, it signifies progress in the company's strategic financial plans and an update to its capital structure.
The backstory
This preferential issue is a mechanism for the company to raise capital from a select group of investors at a pre-determined price. The process involves board approval, valuation reports, and regulatory compliance to ensure fairness and transparency.
What changes now
The company has cleared key procedural hurdles for the preferential issue. The next steps involve the successful allotment of shares to the identified allottees and subsequent filings with regulatory authorities. The company also announced its 16th Annual General Meeting (AGM) will be held on September 14, 2026, via video conference.
Risks to watch
Investors should monitor the successful completion of the share allotment process and any potential delays. Changes in market conditions could also impact the perception of the issue's attractiveness.
Context metrics (time-bound)
- Preferential Issue Date: Board approval on August 17, 2026.
- Valuation Date: August 14, 2026.
- Issue Price: Rs 280 per equity share.
- Total Shares: 16,02,870.
- Approx. Amount Raised: Rs 44.88 crore.
- Number of Allottees: 190.
- AGM Date: September 14, 2026.